Nalbuphine Hydrochloride Injection, Solution
Product Images NDC 71872-7320

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Nalbuphine Hydrochloride (NDC 71872-7320). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7320.pdp (7320)

This text provides information about Nalbuphine Hydrochloride Injection with a concentration of 200 mg/10 mL (20 mg/mL) in a multiple-dose flip-top vial. It includes details on the composition, instructions for use, storage conditions, and distributor information. The injection is suitable for intravenous, intramuscular, or subcutaneous administration and contains nalbuphine HC!, buffers, and preservatives. The usual dosage instructions are specified in the insert. Users are advised to follow aseptic techniques during usage. The injectable must be protected from light and stored at room temperature. The manufacturer is NDG with lot number and expiration date provided.*

FDA Label Image

Logo (Image 01)

FDA Label Image

Nalb.pdp (Nalb)

This text provides information about a 10 mL multiple-dose solution for intravenous, subcutaneous, or intramuscular use. It is distributed by Hospira, Inc. and contains nalbuphine HCI along with other ingredients such as buffers and preservatives. The solution is sterile, nonpyrogenic, and should be protected from light and stored at controlled room temperature. The lot number, expiration date, and prescription-only notice are also included in the text.*

FDA Label Image

Chemical Structure (Nalbuphine 02)

FDA Label Image

Logo (Nalbuphine 03)

FDA Label Image

Principal Display Panel (10 mL Vial Carton)

This text appears to be a detailed description of a medication labeled as "Auoxy 184." The medication is in a flip-top vial for single-dose use and contains nalbuphine HCI, sodium chrate, dihydrate, clric acid, anhydrous, methylparaben, and propylparaben as well as other buffers and preservatives. It advises on dosage, aseptic technique, and to protect from light. The vendor/distributor is Hospira, Inc. This product is to be stored at 20-25°C and should be kept in its carton until ready for use. Additional information includes lot and expiration details along with how to prepare it for use. It appears to be intended for intravenous, intramuscular, or subcutaneous use.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.